Home/Omios Biologics/Ian Mohr, PhD
IM

Ian Mohr, PhD

Scientific Co-founder, Chair of Scientific Advisory Board

Omios Biologics

Therapeutic Areas

Omios Biologics Pipeline

DrugIndicationPhase
Oncolytic Virus therapySolid Tumors (e.g., Breast, Liver, Colon)Pre-clinical
Vaccine platformCancer and Infectious DiseasesPre-clinical
Gene Delivery platformSolid TumorsPre-clinical